|
||||||
In Business 32 Years - Since 1980 |
THE CURRENT TIME at LC Labs is: |
|||||
|
MSDS by Catalog Number |
|
Product # |
Name |
|---|---|
Ascomycin, >99% |
|
Axitinib, Free Base, >99% |
|
A-769662, >99% |
|
Atorvastatin, Hemicalcium Salt, Sesquihydrate, >98% |
|
6"-O-Acetylgenistin, >98% |
|
ADMB, >99% |
|
17-AAG, >99% |
|
6"-O-Acetyldaidzin, >98% |
|
Adenosine 3',5'-Cyclic-monophosphothioate, Sp-Isomer, Triethylammonium Salt, >98% |
|
6"-O-Acetylglycitin, >98% |
|
Anhydroryanodine, >99% |
|
Afatinib, Free Base, >99% |
|
Adenosine 3',5'-Cyclic-monophosphothioate, Rp-Isomer, Triethylammonium Salt, >98% |
|
Bafilomycin A1, >95% |
|
Bortezomib, Free Base, >99% |
|
Bisindolylmaleimide V, >96% |
|
Bosutinib, Free Base, >99% |
|
Bis-tyrphostin, >99% |
|
Bexarotene, Free Acid, >99% |
|
Bisindolylmaleimide I, Free Base, >99% |
|
Bisindolylmaleimide IV, >96% |
|
Bimatoprost, >98% |
|
Bryostatin 2, >99% |
|
Bisindolylmaleimide III, >99% |
|
Bisindolylmaleimide VII, >96% |
|
Bisindolylmaleimide II, >99% |
|
Bisindolylmaleimide I, Hydrochloride, >99% |
|
Bryostatin 1, >99% |
|
BIIB021, Free Base, >99% |
|
Bisindolylmaleimide X, Hydrochloride Salt, >99% |
|
Bisindolylmaleimide IX, Methanesulfonate Salt, >99% |
|
Bisindolylmaleimide VIII, Acetate Salt, >99% |
|
Brefeldin A, >99% |
|
Bisindolylmaleimide XI, Hydrochloride Salt, >99% |
|
Bisindolylmaleimide VI, >96% |
|
Canertinib, Dihydrochloride Salt, >99% |
|
Celecoxib, >99% |
|
Carboplatin, >99% |
|
CI-994, Free Base, >99% |
|
Capecitabine, >99% |
|
Cisplatin, >99% |
|
Chelerythrine Chloride, >99% |
|
Croton Oil |
|
Camptothecin, >98% |
|
Calyculin A, >98% |
|
Cediranib, Free Base, >98% |
|
Ceramide-C16 |
|
Cypermethrin, >99% |
|
Cyclosporin A, >99% |
|
CHIR99021, Free Base, >99% |
|
Crizotinib, Free Base, >99% |
|
CUDC-101, Free Base, >99% |
|
Cyclopamine, Free Base, 99% |
|
Ceramide-C6 |
|
Ceramide-C2 |
|
Docetaxel, >99% |
|
9,21-Didehydroryanodine, >96% |
|
12-Deoxyphorbol 13-Isobutyrate 20-Acetate, >99% |
|
12-Deoxyphorbol 13-Tetradecanoate, >99% |
|
Doramapimod, Free Base, >98% |
|
Daidzein, >99% |
|
Dasatinib, Free Base, >99% |
|
17-DMAG, Hydrochloride Salt, >99% |
|
Dovitinib, Free Base, >99% |
|
Dovitinib, Lactate Salt, >99% |
|
Doxorubicin, Hydrochloride Salt, >99% |
|
Doxorubicin, Free Base, >99% |
|
12-Deoxyphorbol 13-Isobutyrate, >99% |
|
Deltamethrin |
|
DHI, >99% |
|
12-Deoxyphorbol 13-Phenylacetate 20-Acetate, >99% |
|
Daidzin, >99% |
|
1,4-Dimethylendothall, Disodium Salt, >99% |
|
12-Deoxyphorbol 13-Phenylacetate, >99% |
|
(R,S)-2,3-Dihydrodaidzein, >99% |
|
12-Deoxyphorbol 13-Angelate 20-Acetate, >99% |
|
Endothall Thioanhydride, >99% |
|
Entinostat, Free Base, >99% |
|
Erlotinib, Hydrochloride Salt, >99% |
|
Everolimus, >99% |
|
Eptaplatin, >99% |
|
Etoposide 4'-Phosphate, Free Acid |
|
Etoposide |
|
Endothall |
|
Enzastaurin, Free Base, >99% |
|
Erlotinib, Free Base, >99% |
|
Epothilone B, Free Base, >99% |
|
(R,S)-Equol, >99% |
|
Epirubicin, Hydrochloride Salt/b>, >99% |
|
Fingolimod, Hydrochloride Salt, >98% |
|
Fasudil, Monohydrochloride Salt, >99% |
|
FK-506, >99% |
|
Fenvalerate |
|
Forskolin, >99% |
|
Glycitein, >99% |
|
Glycitin, >99% |
|
Gemcitabine, Hydrochloride Salt, >99% |
|
Gemcitabine, Free Base, >99% |
|
Gefitinib, Free Base, >99% |
|
Geldanamycin, >99% |
|
Genistin, >99% |
|
GW2580, Free Base, >99% |
|
Genistein, >99% |
|
Gö 6976, >99% |
|
GDC-0941, Free Base, >99% |
|
HA 1077, Dihydrochloride Salt, >99% |
|
H-9, Dihydrochloride Salt, >99% |
|
H-8, Dihydrochloride Salt, >99% |
|
HA-1004, Dihydrochloride Salt, >99% |
|
H-7, Dihydrochloride Salt, >99% |
|
H-89, Dihydrochloride Salt, >99% |
|
(-)-Huperzine A, >99% |
|
HA-100, Dihydrochloride Salt, >99% |
|
D-myo-Inositol 1,4,5-Trisphosphate, Hexapotassium Salt, >99% |
|
(-)-Indolactam V, >99% |
|
6'-Iodoresiniferatoxin, >99% |
|
Iso-H-7, Dihydrochloride, >99% |
|
Irinotecan, Hydrochloride Salt, Trihydrate, >99% |
|
Imiquimod, Free Base, >99% |
|
Iniparib, 99% |
|
Imatinib, Methanesulfonate Salt, >99% |
|
Imatinib, Free Base, >99% |
|
Ionomycin, Free Acid, >99% |
|
Ingenol 3-Angelate, >99% |
|
L-myo-Inositol 1,4,5-trisphosphate, Hexapotassium Salt, >99% |
|
5'-Iodoresiniferatoxin, >99% |
|
Ionomycin, Calcium Salt, >99% |
|
Iso-olomoucine, >99% |
|
Ingenol 3,20-Dibenzoate, >99% |
|
Ingenol 3-Benzoate, >99% |
|
Ingenol, >99% |
|
Ingenol 3-Angelate 20-Acetate, >99% |
|
(+)-Indolactam V, >99% |
|
K252a, >99% |
|
KN-62, >99% |
|
KU-0063794, Free Base, >99% |
|
K252c, >99% |
|
Lapatinib, Di-p-Toluenesulfonate Salt, >99% |
|
Lapatinib, Free Base, >99% |
|
Lavendustin A, >97% |
|
(R,S)-Lenalidomide, Free Base, >99% |
|
Leptomycin B, Free Acid, >99% |
|
Lestaurtinib, >99% |
|
Lavendustin C, >97% |
|
LY 294002, >99% |
|
Lavendustin A, Trifluoroacetate Salt, >97% |
|
Lavendustin B, >97% |
|
Lavendustin A Methyl Ester, >97% |
|
Mocetinostat, Free Base, >99% |
|
4-O-Methylphorbol 12-Myristate 13-Acetate, >99% |
|
Motesanib, Free Base, 99% |
|
Motesanib, Diphosphate Salt, >99% |
|
MDL-27,032 |
|
Mezerein, >99% |
|
6"-O-Malonylglycitin, Free Acid, >98% |
|
Montelukast, Sodium Salt, >99% |
|
Mubritinib, Free Base, >99% |
|
Methyl Okadaate, >98% |
|
4-O-Methylphorbol 12,13-Dibutyrate, >99% |
|
6"-O-Malonyldaidzin, Free Acid, >98% |
|
Masitinib, Free Base, >99% |
|
Mycophenolic Acid, Free Acid, >99% |
|
6"-O-Malonylgenistin, Free Acid, >98% |
|
NVP-BEZ235, Free Base, >99% |
|
NVP-AUY922, Free Base, >99% |
|
Nedaplatin, >99% |
|
Neratinib, Free Base, >99% |
|
1-Nor-okadaone, >98% |
|
Nilotinib, Free Base, >99% |
|
(-)-7-Octylindolactam V, >99% |
|
ODQ, Free Base, >99% |
|
Okadaic Acid, Free Acid, >98% |
|
Okadaol, >98% |
|
Olomoucine, >99% |
|
20-Oxo-20-deoxyphorbol 12-Myristate 13-Acetate, >98% |
|
OSU-03012, Hydrochloride Salt, >99% |
|
20-Oxo-20-deoxyphorbol 12,13-Dibutyrate, >98% |
|
Okadaic Acid, Sodium Salt, >98% |
|
Okadaic Acid, Ammonium Salt, >98% |
|
Oxaliplatin, >99% |
|
Okadaic Acid, Potassium Salt, >98% |
|
(+)-7-Octylindolactam V, >99% |
|
Olaparib, >99% |
|
Phorbol, >99% |
|
Phorbol 13,20-Diacetate, >99% |
|
| 4α-Phorbol, >99% |
|
anti-Protein Kinase Cµ Monoclonal Antibody |
|
4α-Phorbol 12,13-Diacetate, >99% |
|
Phorbol 12-Myristate 13-Acetate, >99.5% |
|
| Phorbol 12,13,20-Triacetate, >99% | |
Phorbol 12,13-Didecanoate, >99% |
|
4α-Phorbol 12,13-Didecanoate, >99% |
|
PDDHV, >99% |
|
Phorbol 12-Myristate, >99% |
|
Phorbol 12,13-Dibenzoate, >99% |
|
PD 173074, Free Base, >99% |
|
Phorbol 12-Acetate, >99% |
|
Panobinostat, Free Base, >99% |
|
Phorbol 12,13-Dihexanoate, >99% |
|
PDNHV, >99% |
|
Phorbol 13-Acetate, >99% |
|
PD 98059, >99% |
|
Prostratin, >99% |
|
4α-Phorbol 12,13-Dibutyrate, >99% |
|
Phorbol 12,13-Dibutyrate, >99% |
|
Phorbol 12,13-Diacetate, >99% |
|
Picoplatin, >99% |
|
PD 153035, >99% |
|
Pimecrolimus, >98% |
|
Phorbol 12-Decanoate, >99% |
|
PPAHV, >99% |
|
Perifosine, >99% |
|
PP242, Free Base, >99% |
|
Pazopanib, Free Base, >99% |
|
Phorbol 13-Butyrate, >99% |
|
Prasugrel, Free Base, >99% |
|
PIK-75, Hydrochloride Salt, >99% |
|
Pemetrexed, Disodium Salt, Heptahydrate, >99% |
|
Phorbol 13-Myristate, >99% |
|
Phorbol 13-Decanoate, >99% |
|
PX-866, >99% |
|
PKC412, >99% |
|
PIK-75, Free Base, >99% |
|
Phorbol 12-Butyrate, >99% |
|
PD 184352, Free Base, >99% |
|
4α-Phorbol 12-Myristate 13-Acetate, >99% |
|
PIK-90, Free Base, >99% |
|
Paclitaxel, >99.5% |
|
PD 325901, Free Base, >99% |
|
Quizartinib, Free Base, >99% |
|
Roscovitine, Free Base, >99% |
|
Ryanodine, High Purity, >99% |
|
Retaspimycin, Hydrochloride Salt, >99% |
|
(R,S)-Rolipram, >99% |
|
Rapamycin, >99% |
|
Ruxolitinib, Free Base, >99% |
|
Ruxolitinib, Phosphate Salt, >99% |
|
Resiniferatoxin, >99% |
|
Ryanodine, Technical Grade, >96% (Contains Ryanodine and 9,21-Didehydroryanodine) |
|
Ridaforolimus, >99% |
|
Rivaroxaban, >99% |
|
Ramatroban, Free Acid, >99% |
|
Resiniferonol 9,13,14-Orthophenylacetate, >99% |
|
Rottlerin, >98% |
|
SB 202190, Free Base, >99% |
|
StemRegenin 1, Free Base, >99% |
|
SB 203580, Free Base, >99% |
|
Sapintoxin D, >99% |
|
Selumetinib, Free Base, 98% |
|
SB 225002, >99% |
|
D-erythro-Sphingosine 1-Phosphate, >99% |
|
Sepantronium Bromide, 98% |
|
SP600125, >99% |
|
Satraplatin, >99% |
|
Sorafenib, p-Toluenesulfonate Salt, >99% |
|
Sorafenib, Free Base, >99% |
|
Sodium Orthovanadate, UltraPure Research Grade, >99.9% |
|
Sunitinib, Malate Salt, >99% |
|
Sunitinib, Free Base, >99% |
|
Saracatinib, Free Base, >99% |
|
Sodium Fluoride, UltraPure Research Grade, >99.9% |
|
Staurosporine, >99% |
|
Stauprimide, >99% |
|
Tofacitinib, Free Base, >99% |
|
Tyrphostin B48, >99% |
|
Tyrphostin RG 13022, >99% |
|
Tyrphostin RG 14620, >99% |
|
Tyrphostin AG 1288, >99% |
|
Tozasertib, Free Base, 99% |
|
Tyrphostin SU1498, >99% |
|
Tyrphostin B50, >99% |
|
Tyrphostin A10, >99% |
|
Thapsigargin, >99% |
|
Tyrphostin B56, >99% |
|
Tyrphostin A36, >99% |
|
Tyrphostin AG 1478, Methanesulfonate Salt, >99% |
|
Tyrphostin AG 1296, >98% |
|
Tyrphostin AG 808, >99% |
|
Thapsigargicin, >99% |
|
Tyrphostin B66, >99% |
|
Trilobolide, >99% |
|
Tinyatoxin, >99% |
|
Tyrphostin A46, >99% |
|
Tyrphostin AG 1433, >99% |
|
Thymeleatoxin, >99% |
|
Tivozanib, Free Base, 99% |
|
Tyrphostin AG 1295, >99% |
|
Tyrphostin A25, >99% |
|
Tyrphostin B7, >99% |
|
Tyrphostin AG 957, >98% |
|
Tyrphostin A9, >99% |
|
Tyrphostin A47, >99% |
|
Tyrphostin AG 879, >99% |
|
Tyrphostin AG 1478, Free Base, >99% |
|
Thapsigargin Epoxide, >99% |
|
Tandutinib, Free Base, >99% |
|
Temsirolimus, >99% |
|
Tyrphostin A23, >99% |
|
Tyrphostin A51, >99% |
|
Tyrphostin B44, >99% |
|
Tyrphostin A8, >99% |
|
Tyrphostin A63, >99% |
|
Tipifarnib, Free Base, >99% |
|
Tyrphostin AG 490, >99% |
|
Tyrphostin B52, >99% |
|
Topotecan, Hydrochloride Salt, >99% |
|
Tyrphostin B46, >99% |
|
Tyrphostin A1, >99% |
|
Tyrphostin A48, >99% |
|
U0126, >99% |
|
Vemurafenib, Free Base, >99% |
|
Vismodegib, Free Base, >99% |
|
Vatalanib, Dihydrochloride Salt, >99% |
|
Vatalanib, Free Base, >99% |
|
Vorinostat, >99% |
|
Vinorelbine, Ditartrate Salt, >99% |
|
Vinorelbine, Free Base, >98% |
|
Vargatef, Free Base, >99% |
|
VX-702, Free Base, >99% |
|
Vandetanib, Free Base, >99% |
|
Wortmannin, >99% |
|
ZSTK474, Free Base, >99% |
|
Zotarolimus, >98% |
Our products are for laboratory research only and are sold only to qualified research institutions, not to individuals or patients nor for veterinary use.